- Home >
- Life Sciences >
- Pharmaceutical >
Indian Bulk Drugs
Indian Bulk Drugs
- Report price : $ 800
- Publication date : January 2008
Indian Bulk Drugs
Introduction
The Indian API (bulk drugs) manufacturing industry is estimated to have touched USD4.10 billion by 2007, growing at CAGR of 18.81% during 2003-07. India ranks fourth in terms of volume among the top 15 drug manufacturing countries. Cygnus releases the latest version of the Indian Bulk Drugs Industry Insight to capture the present domestic market scenario, along with the major players and their key financials
Key Findings & Highlights
- The global pharmaceutical market was valued at USD712 billion in 2007.
- According to IMS Health, treatment costs per day declined by 20-40% in 2007 in therapy Areas
- Generics continued to replace branded prescriptions in the major therapeutic classes, increasing their share of total dispensed prescriptions to 67.3 %.
- In 2007, North America, which accounts for 45.9% of global pharmaceutical sales, grew by 4.2% to USD304.5 billion
- The market size for the global bulk drugs was USD77.32 billion in 2005 and was estimated to be USD92.21 billion in 2007
- Indian companies have the distinction of developing cost-effective technologies for manufacturing bulk drugs and intermediates that conform to global standards.
- Understand the global bulk drug market scenario
- Know investment opportunities according to the trend analysis
- Reveals the demand analysis of the bulk drugs industry
- Assess the cost effective technologies for manufacturing bulk drugs
RELATED REPORTS
Russian Pharma Sector Analysis
- $ 1 100
- January 2008
According to “Russian Pharma Sector Analysis”, the Russian pharmaceutical market grew at a slow pace in 2007 but it still is attractive as compared to previous years that recorded no-so-impressive performance due to the state segment. In the Russian pharma market, both the retail segment and pa ...
Industries : Pharmaceutical
Company Profile - A.S.V., Inc.
- $ 400
- January 2008
Company Profile will assists individual investors, managers and companies in evaluating opportunities, trends, market innovations, and selecting appropriate information solutions in order to make effective decisions. The report has been made after extensive research using the data available from rel ...
Industries : Pharmaceutical
Company Profile - GlaxoSmithKline Plc
- $ 400
- January 2008
Company Profile will assists individual investors, managers and companies in evaluating opportunities, trends, market innovations, and selecting appropriate information solutions in order to make effective decisions. The report has been made after extensive research using the data available from rel ...
Industries : Pharmaceutical
Company Profile - Coast Distribution System, Inc.
- $ 400
- January 2008
Company Profile will assists individual investors, managers and companies in evaluating opportunities, trends, market innovations, and selecting appropriate information solutions in order to make effective decisions. The report has been made after extensive research using the data available from rel ...
Industries : Pharmaceutical
Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition
- $ 3 500
- January 2008
Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are ...
Industries : Pharmaceutical
Indian Vaccines Industry
- $ 700
- August 2008
Vaccine manufacturers from all over the world have been involved in a stalemate with governments regarding supply and demand. While governments are reluctant to ensure steady demand for vaccines unless the manufacturers can prove their ability to increase their supply, the latter are apprehensive a ...
Industries : Pharmaceutical
CRAMS In India
- $ 700
- August 2008
Introduction With a number of blockbuster drugs getting off patent in the coming years and increasing R&D costs coupled with low R&D productivity, major pharmaceutical companies worldwide are finding it difficult to maintain their bottom lines. They have taken recourse to outsourcing part of ...
Industries : Pharmaceutical
Vaccine Technologies and Global Markets
- $ 4 850
- January 2008
Through the late 1980s, the vaccine market was beset by limited portfolios and profitability. Recent technological breakthroughs in understanding disease mechanisms, probably necessitated by pandemics and vaccine shortages, have provided momentum for research in the past decade or so. This is appare ...
Industries : Pharmaceutical
Monoclonal Therapeutics and Companion Diagnostic Products
- $ 4 850
- January 2008
BCC's goal in conducting this study was to determine the current status of the global therapeutic and diagnostic markets for monoclonal antibodies and their growth potential over a 5 year period from 2007 to 2012. We were particularly interested in the position of the antibody market in the immediat ...
Industries : Pharmaceutical
Drug Discovery Technologies
- $ 4 850
- November 2007
This report contains: Descriptions of various drug discovery-related products including bioanalytical instruments, high throughput screening, informatics and microarrays; The current market status of drug discovery technologies, trends and forecasts for growth over the next 5 years; Discussion of ne ...
Industries : Pharmaceutical
Related industries
reportlinker.com © Copyright 2009. All rights reserved